ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,239.30
1.10%
Dow Jones
43,870.35
0.00%
Gold vs US Dollar
2,694.355
0.94%
Brent Oil
73.67
-0.35%
Bitcoin
98,211.11
-0.31%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Crossject (ALCJ) Share Price

ALCJ Crossject

1.98
0.032 (1.64%)
Last Updated: 13:53:31
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Crossject EU:ALCJ Euronext Ordinary Share FR0011716265 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.032 1.64 1.98 1.96 1.978 1.99 1.93 1.934 15,958 13:53:31   
 Type  Size  Price  Time  Units 
  220 1.98 13:49:25 EUR
 
Recent News
DateTimeSource
HeadlineMore ALCJ News
20/11/202415:11UKREGInformation relative au nombre total de droits de vote et d’actions composant le capital social
13/11/202416:30UKREGCrossject démontre à nouveau la facilité d’utilisation de son auto-injecteur ZENEO® dans une nouvelle étude en conditions extrêmes
13/11/202416:30UKREGCrossject’s ZENEO® Auto-Injector's usability further demonstrated in extreme HAZMAT conditions
22/10/202405:30GLOBECrossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization
22/10/202405:30UKREGCrossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization
07/10/202417:00UKREGCrossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
07/10/202417:00UKREGCrossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
Period
Draw mode
Data Downloads for ALCJ

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Crossject Articles

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Level 2 Lite

1 year 40%, 2 years 50% and *3 years 60%
EU Flag

*Across 3 years £2132.64 only £853.06